These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Advantage of combined therapy with captopril and nitrates in severe congestive heart failure. Halon DA, Rosenfeld T, Hardoff R, Lewis BS. Isr J Med Sci; 1988 Nov; 24(11):664-70. PubMed ID: 3063685 [Abstract] [Full Text] [Related]
6. Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure. Packer M, Meller J, Medina N, Yushak M. Am J Cardiol; 1983 Jan 01; 51(1):183-8. PubMed ID: 6336876 [Abstract] [Full Text] [Related]
8. Synergistic effect of captopril and dobutamine on left ventricular pressure-volume and pressure-shortening relations in severe cardiac failure. Lewis BS, Halon DA, Rodeanu ME, Merdler A, Saggie Y, Hardoff R. Int J Cardiol; 1988 Nov 01; 21(2):157-66. PubMed ID: 3066763 [Abstract] [Full Text] [Related]
10. Assessment of vasodilator therapy in patients with severe congestive heart failure: limitations of measurements of left ventricular ejection fraction and volumes. Firth BG, Dehmer GJ, Markham RV, Willerson JT, Hillis LD. Am J Cardiol; 1982 Nov 01; 50(5):954-9. PubMed ID: 6291370 [Abstract] [Full Text] [Related]
11. Effect of captopril on left ventricular end-systolic pressure-volume and stress-shortening relations in severe cardiac failure. Lewis BS, Halon DA, Rodeanu ME, Merdler A, Saggie Y, Schneider H, Rosenfeld T, Hardoff R. Clin Cardiol; 1987 Jun 01; 10(6):340-4. PubMed ID: 3297444 [Abstract] [Full Text] [Related]
12. Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure. Awan NA, Evenson MK, Needham KE, Win A, Mason DT. Am Heart J; 1981 Jan 01; 101(1):22-31. PubMed ID: 6257100 [Abstract] [Full Text] [Related]
13. Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders. Packer M, Medina N, Yushak M. Am J Cardiol; 1984 Oct 01; 54(7):771-7. PubMed ID: 6091434 [Abstract] [Full Text] [Related]
16. Effects of verapamil and propranolol on left ventricular systolic function and diastolic filling in patients with coronary artery disease: radionuclide angiographic studies at rest and during exercise. Bonow RO, Leon MB, Rosing DR, Kent KM, Lipson LC, Bacharach SL, Green MV, Epstein SE. Circulation; 1982 Jun 01; 65(7):1337-50. PubMed ID: 7074794 [Abstract] [Full Text] [Related]
17. Comparative effects of propranolol and verapamil alone and in combination on left ventricular function and volumes in patients with chronic exertional angina: a double-blind, placebo-controlled, randomized, crossover study with radionuclide ventriculography. Johnston DL, Gebhardt VA, Donald A, Kostuk WJ. Circulation; 1983 Dec 01; 68(6):1280-9. PubMed ID: 6315259 [Abstract] [Full Text] [Related]
18. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure. Halperin JL, Faxon DP, Creager MA, Bass TA, Melidossian CD, Gavras H, Ryan TJ. Am J Cardiol; 1982 Nov 01; 50(5):967-72. PubMed ID: 6182786 [Abstract] [Full Text] [Related]
19. Effect of oral propranolol on rest and exercise left ventricular ejection fraction, volumes, and segmental wall motion in patients with angina pectoris. Assessment with equilibrium gated blood pool imaging. Dehmer GJ, Falkoff M, Lewis SE, Hillis LD, Parkey RW, Willerson JT. Br Heart J; 1981 Jun 01; 45(6):656-66. PubMed ID: 7259915 [Abstract] [Full Text] [Related]